Abstract: A network node is adapted to wirelessly receive content data from remote wireless devices if they have been provisioned to the network node via provisioning data. The network node includes a memory for storing first provisioning data, a transceiver adapted to transmit a portion of the first provisioning data for receipt and storage by a second node, receive a portion of second provisioning data stored in the second node, communicate with a remote cloud based source of provisioning data, transmit content data communicated to the first node by a wireless device to a remote data store, and a programmable processor. The processor determines whether a detected device has or has not been formerly provisioned with the first node. If the detected device has not been formerly provisioned with the first node, and if provisioning data for the detected device is not available in the first or the second provisioning data, provisioning data for the detected device is obtained from the remote cloud based source.

Abstract: A system for transmitting and receiving medical vital signs from a “smart” vital sign apparatus over multi-protocol communication channels to and from a remote electronic health record database that may include a plurality of vital sign sources that communicate over a plurality of standard communication channels including: Bluetooth, LoRa, WiFi, cellular, Ethernet or other direct IP paths. The system reduces the volume of data transferred and extends BLE security.

Abstract: A gateway has a transceiver for communicating with Bluetooth vitals devices (BVDs) and a processor and program instructions. The gateway receives and stores pairing keys from one or more of the BVDs for provisioning the BVDs to the gateway, receives vital sign information from the BVDs, stores the pairing keys in a remote trusted server, and communicates with other gateways in the environment. The gateway also retrieves pairing keys for unprovisioned BVDs from either another gateway or the remote trusted server, and creates a remote private network for secure communications among two or more of the gateway, the remote server, an electronic health records store, caregivers, physicians, or a personalized data service.

Abstract: A system for transmitting and receiving medical vital signs from a “smart” vital sign apparatus over multi-protocol communication channels to and from a remote electronic health record database that may include a plurality of vital sign sources that communicate over a plurality of standard communication channels including: Bluetooth, LoRa, WiFi, cellular, Ethernet or other direct IP paths. The system reduces the volume of data transferred, extends BLE security and protects private data including account holder and patient information.

Abstract: A system for transmitting and receiving medical vital signs from a “smart” vital sign apparatus over multi-protocol communication channels to and from a remote electronic health record database that may include a plurality of vital sign sources that communicate over a plurality of standard communication channels including: Bluetooth, LoRa, WiFi, cellular, Ethernet or other direct IP paths. The system reduces the volume of data transferred and extends BLE security.

Abstract: Vital sign data is communicated from one or more Bluetooth vital sign measuring devices (BVSMD) to one or more gateways located within an environment. At least one of the gateways communicates the vital sign data to an endpoint, that may include electronic health records, via a wide area network (WAN). The gateways communicate among themselves using one or more of a plurality of protocols, such as LoRa, WiFi, cellular, ethernet or direct IP. Each gateway may be capable of forming a mesh network with other gateways. Each gateway may also share a Bluetooth bonding key with another gateway, so as to allow BVSMD's to communicate with other gateways without individually pairing each BVSMD to the other gateways. The BVSMD's may be Bluetooth Low Energy (BLE) devices. Each gateway may be capable of periodically generating a random access address that is mapped with a BVSMD MAC address. The access address is used for communication between the BVSMD and the gateway for enhanced security.

Abstract: Controllable three-dimensional (3D) virtual dioramas in a rendered 3D environment such as a virtual reality or augmented reality environment including one or more rendered objects. 3D diorama is associated with a spatial computing content item such as a downloadable application executable by a computing device. 3D diorama assets may include visual and/or audio content and are presented with rendered 3D environment objects in a composite view, which is presented to a user through a display of computing device. 3D diorama is rotatable in composite view, and at least one 3D diorama asset at least partially occludes, or is at least partially occluded by, at least one rendered 3D environment object. 3D diorama may depict or provide a preview of a spatial computing user experience generated by the downloadable application.

Abstract: A system for transmitting and receiving medical vital signs from a “smart” vital sign apparatus over multi-protocol communication channels to and from a remote electronic health record database that may include a plurality of vital sign sources that communicate over a plurality of standard communication channels including: Bluetooth, LoRa, WiFi, cellular, Ethernet or other direct IP paths. The system reduces the volume of data transferred and extends BLE security.

Abstract: A system for transmitting and receiving medical vital signs from a “smart” vital sign apparatus over multi-protocol communication channels to and from a remote electronic health record database that may include a plurality of vital sign sources that communicate over a plurality of standard communication channels including: Bluetooth, LoRa, WiFi, cellular, Ethernet or other direct IP paths. The system reduces the volume of data transferred, extends BLE security and protects private data including account holder and patient information.

Abstract: This patent application has as purpose the application/utilization of esters and ethers derived from xylitol, obtained by organic synthesis, as alternative emollient, moisturizing, emulsifier and co-emulsifier and preservatives for pharmaceutical, cosmetic and veterinarian products. The molecules required in this invention patent are mainly xylitol esters and ethers associated to the chains of fatty acids and alcohols (FIGS. 1 and 2), applied isolated or in association with other molecules of known preserving and/or moisturizing/emollient actions, such as phenoxyethanol, butylene glycol, glycerin, caprylyl glycol, ethyl hexyl glycerin, phenetyl alcohol, nisin, lactoferrin, among others, as well as in association with other emollient/moisturizing and preservatives for application in cosmetic, pharmaceutical and veterinarian formulations.

Abstract: A composition suitable for application to hair and/or skin comprises Phosphates Esters, such as Xylitol Phosphate Esters and other Polyol Units Phosphoric Acid Esters. This composition can be used to improve or treat skin, including scalp, conditions in cosmetic or pharmaceutical products for acne, dandruff, seborrheic dermatitis and malodor and/or can be incorporate in such formulations as a coemulsifying agent or a preservative, alone or in combination to other emulsifying or preservative agents in order to increase such activities.

Abstract: This patent application has as purpose the application/utilization of esters and ethers derived from xylitol, obtained by organic synthesis, as alternative emollient, moisturizing, emulsifier and co-emulsifier and preservatives for pharmaceutical, cosmetic and veterinarian products. The molecules required in this invention patent are mainly xylitol esters and ethers associated to the chains of fatty acids and alcohols (FIGS. 1 and 2), applied isolated or in association with other molecules of known preserving and/or moisturizing/emollient actions, such as phenoxyethanol, butylene glycol, glycerin, caprylyl glycol, ethyl hexyl glycerin, phenetyl alcohol, nisin, lactoferrin, among others, as well as in association with other emollient/moisturizing and preservatives for application in cosmetic, pharmaceutical and veterinarian formulations.